NGM Biopharmaceuticals Stock (NASDAQ: NGM) stock price, news, charts, stock research, profile.
Open | $1.590 |
Close | $1.590 |
Volume / Avg. | 357.153K / 1.441M |
Day Range | 1.555 - 1.600 |
52 Wk Range | 0.600 - 4.690 |
Market Cap | $134.374M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 7.26% |
Days to Cover | 5.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NGM Biopharmaceuticals (NASDAQ: NGM) through any online brokerage.
Other companies in NGM Biopharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Rani Therapeutics Hldgs (NASDAQ:RANI), Alimera Sciences (NASDAQ:ALIM), Telomir Pharmaceuticals (NASDAQ:TELO) and Milestone Pharmaceuticals (NASDAQ:MIST).
The latest price target for NGM Biopharmaceuticals (NASDAQ: NGM) was reported by Raymond James on Tuesday, March 12, 2024. The analyst firm set a price target for 0.00 expecting NGM to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for NGM Biopharmaceuticals (NASDAQ: NGM) is $1.61 last updated Today at March 28, 2024 at 8:59 AM EDT.
There are no upcoming dividends for NGM Biopharmaceuticals.
NGM Biopharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for NGM Biopharmaceuticals.
NGM Biopharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.